CLOV vs KYMR · rev $1.37B vs rev $47.1M
Clover Health Investments Corp (CLOV) versus Kymera Therapeutics Inc (KYMR) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Kymera Therapeutics Inc (KYMR) is a biotechnology company listed on NASDAQ.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported KYMR revenue for 2024-12-31 was $47.1M. Net income was -$223.9M. Revenue was down 40.1% from 2023-12-31 to 2024-12-31. KYMR currently screens at market cap $7.39B.
CLOV currently screens at market cap $1.55B. KYMR currently screens at market cap $7.39B.
Not investment advice. Open the CLOV and KYMR stock pages for the full models.
Not investment advice.